[CLSTR]
API
< Back to situations

Monitor this situation.

[SITUATION] · [ACTIVE] · [TECHNOLOGY]

2 clusters · 4 sources · 2 days · First seen · Last updated

Lunit medical AI research and model development

Overview

Medical AI company Lunit has presented research regarding its SCOPE AI biomarker platform at the SITC 2026 conference. Collaborative studies with Labcorp and CellCarta utilized AI to analyze histological features in ovarian and bladder cancers, focusing on distinguishing homologous recombination deficiency and understanding the spatial distribution of immune cells in treatment responses.

Following these research developments, Lunit announced the completion of LearningUnit 2.0, a medical-specific foundation model. Developed over ten months for the Ministry of Science and ICT, the 30 billion parameter model was released as open source. Validation studies across nine medical institutions indicated high accuracy in clinical decision support, emergency room triage, and multidisciplinary care planning.

Entities

Lunit · Ministry of Science and ICT · Society for Immunotherapy of Cancer · CellCarta · Hugging Face

Timeline

  1. [TECHNOLOGY] 2 sources
    Lunit develops LearningUnit 2.0 medical AI foundation model

    Lunit has released LearningUnit 2.0, an open-source medical AI foundation model designed to support clinical decision-making and administrative workflows in hospitals.

  2. [TECHNOLOGY] 2 sources
    Lunit presents AI cancer biomarker research at SITC 2026

    Lunit presented AI-driven research at SITC 2026, demonstrating how its Lunit SCOPE platform can analyze ovarian and bladder cancer biomarkers through spatial and histological tissue analysis.

Sources

bosa.co.kr · hellot.net · thebionews.net · venturesquare.net